Assignee
GENEFRONTIER CORP
JP·8 granted patents·3 pending applications·3 citations·filing 2013–2020
Top patents by PatentIndex Score
11 records- 0173US10556967B2Anti-ADAM28 antibody for treating cancerGENEFRONTIER CORP·Filed 2017·Granted Feb 11, 2020·2 cites·14 claims
- 0265US9845364B2Anti-ADAM28 antibody for treating cancerGENEFRONTIER CORP·Filed 2013·Granted Dec 19, 2017·1 cites·13 claims
- 0359US10865247B2Anti-human CD69 antibody, and use thereof for medical purposesGENEFRONTIER CORP·Filed 2020·Granted Dec 15, 2020·0 cites·12 claims
- 0455US10301618B2Efficient method for displaying protein multimerGENEFRONTIER CORP·Filed 2016·Granted May 28, 2019·0 cites·21 claims
- 0555US9289742B2Efficient method for displaying protein multimerGENEFRONTIER CORP·Filed 2013·Granted Mar 22, 2016·0 cites·26 claims
- 0654US12565517B2Cyclic peptide having CTLA-4 inhibitory activity and use thereofGENEFRONTIER CORP·Filed 2020·Granted Mar 3, 2026·0 cites·16 claims
- 0750US2019233521A1Anti-human cd69 antibody, and use thereof for medical purposesGENEFRONTIER CORP·Filed 2018·Application pending·0 cites
- 0848US2015118237A1Anti-human cd69 antibody, and use thereof for medical purposesGENEFRONTIER CORP·Filed 2013·Application pending·0 cites
- 0948US2016304622A1Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseasesGENEFRONTIER CORP·Filed 2014·Application pending·0 cites
- 1046US9617533B2Composition for synthesizing protein with reduced lipopolysaccharide contamination, method for producing protein using said compositionGENEFRONTIER CORP·Filed 2015·Granted Apr 11, 2017·0 cites·14 claims
- 1133US10329358B2Anti-human membrane-type ADAM28 antibodyGENEFRONTIER CORP·Filed 2016·Granted Jun 25, 2019·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when GENEFRONTIER CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →